SEER is an authoratitive source of information on cancer incidence and survival in the United States. SEER currently collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 28 percent of the U.S. population.
Transient abnormal myelopoiesis (TAM) is a unique disorder of Down syndrome newborns that presents with clinical and morphologic findings indistinguishable from AML. The blasts have morphologic and immunologic features of megakaryocytic lineage. This is part of the myeloid proliferations with Down syndrome WHO group, which also includes myeloid leukemia associated with Down syndrome (see 9898/3).
Definitive Diagnostic Methods
Negative: Myeloperoxidase, CD15, CD14, Glycophorin A